133 related articles for article (PubMed ID: 36750202)
1. Safety of levofloxacin as an antibiotic prophylaxis in the induction phase of children newly diagnosed with acute lymphoblastic leukemia: an interim analysis of a randomized, open-label trial in Brazil.
Dufrayer MC; Rechenmacher C; Meneses CF; Monteiro YMC; Carlesse FAMC; Motta F; Daudt LE; Michalowski MB
Braz J Infect Dis; 2023; 27(2):102745. PubMed ID: 36750202
[TBL] [Abstract][Full Text] [Related]
2. Levofloxacin Prophylaxis During Induction Therapy for Pediatric Acute Lymphoblastic Leukemia.
Wolf J; Tang L; Flynn PM; Pui CH; Gaur AH; Sun Y; Inaba H; Stewart T; Hayden RT; Hakim H; Jeha S
Clin Infect Dis; 2017 Nov; 65(11):1790-1798. PubMed ID: 29020310
[TBL] [Abstract][Full Text] [Related]
3. Effect of Levofloxacin Prophylaxis on Bacteremia in Children With Acute Leukemia or Undergoing Hematopoietic Stem Cell Transplantation: A Randomized Clinical Trial.
Alexander S; Fisher BT; Gaur AH; Dvorak CC; Villa Luna D; Dang H; Chen L; Green M; Nieder ML; Fisher B; Bailey LC; Wiernikowski J; Sung L;
JAMA; 2018 Sep; 320(10):995-1004. PubMed ID: 30208456
[TBL] [Abstract][Full Text] [Related]
4. Prophylactic Use Of Levofloxacin During Induction Of Acute Lymphoblastic Leukaemia In Children-Experience From Pakistan.
Rehman P; Shaukat Z; Saeed H; Raza A; Anjum S; Wali RM
J Pak Med Assoc; 2023 Oct; 73(10):2065-2068. PubMed ID: 37876072
[TBL] [Abstract][Full Text] [Related]
5. Prophylactic levofloxacin to prevent infections in newly diagnosed symptomatic myeloma: the TEAMM RCT.
Drayson MT; Bowcock S; Planche T; Iqbal G; Pratt G; Yong K; Wood J; Raynes K; Higgins H; Dawkins B; Meads D; Hulme CT; Whittaker AC; Hawkey P; Low E; Dunn JA
Health Technol Assess; 2019 Nov; 23(62):1-94. PubMed ID: 31690402
[TBL] [Abstract][Full Text] [Related]
6. Levofloxacin prophylaxis in patients with newly diagnosed myeloma (TEAMM): a multicentre, double-blind, placebo-controlled, randomised, phase 3 trial.
Drayson MT; Bowcock S; Planche T; Iqbal G; Pratt G; Yong K; Wood J; Raynes K; Higgins H; Dawkins B; Meads D; Hulme CT; Monahan I; Karunanithi K; Dignum H; Belsham E; Neilson J; Harrison B; Lokare A; Campbell G; Hamblin M; Hawkey P; Whittaker AC; Low E; Dunn JA;
Lancet Oncol; 2019 Dec; 20(12):1760-1772. PubMed ID: 31668592
[TBL] [Abstract][Full Text] [Related]
7. Levofloxacin prophylaxis for pediatric leukemia patients: Longitudinal follow-up for impact on health care-associated infections.
Davis A; Stevens AM; Brackett J; Marquez L; Foster CE; Sauer HE; Campbell JR
Pediatr Blood Cancer; 2022 Jul; 69(7):e29525. PubMed ID: 35029328
[TBL] [Abstract][Full Text] [Related]
8. Moxifloxacin versus levofloxacin or ciprofloxacin prophylaxis in acute myeloid leukemia patients receiving chemotherapy.
Przybylski DJ; Reeves DJ
Support Care Cancer; 2017 Dec; 25(12):3715-3721. PubMed ID: 28660351
[TBL] [Abstract][Full Text] [Related]
9. Comparative effectiveness and safety of antibiotic prophylaxis during induction chemotherapy in children with acute leukaemia: a systematic review and meta-analysis.
Yang M; Lu X; Xin L; Luo J; Diao S; Jia Z; Cheng G; Zeng L; Zhang L
J Hosp Infect; 2023 Jun; 136():20-29. PubMed ID: 36921630
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of levofloxacin as an antibacterial prophylaxis for acute leukemia patients receiving intensive chemotherapy: a systematic review and meta-analysis.
Owattanapanich W; Chayakulkeeree M
Hematology; 2019 Dec; 24(1):362-368. PubMed ID: 30880638
[TBL] [Abstract][Full Text] [Related]
11. Levofloxacin for febrile neutropenia prophylaxis in acute myeloid leukemia patients associated with reduction in hospital admissions.
Lee SSF; Fulford AE; Quinn MA; Seabrook J; Rajakumar I
Support Care Cancer; 2018 May; 26(5):1499-1504. PubMed ID: 29170868
[TBL] [Abstract][Full Text] [Related]
12. A comparison of levofloxacin and oral third-generation cephalosporins as antibacterial prophylaxis in acute leukaemia patients during chemotherapy-induced neutropenia.
Yemm KE; Barreto JN; Mara KC; Dierkhising RA; Gangat N; Tosh PK
J Antimicrob Chemother; 2018 Jan; 73(1):204-211. PubMed ID: 29040595
[TBL] [Abstract][Full Text] [Related]
13. Fluoroquinolone prophylaxis does not increase risk of neuropathy in children with acute lymphoblastic leukemia.
Karol SE; Sun Y; Tang L; Pui CH; Ferrolino J; Allison KJ; Cross SJ; Evans WE; Crews KR; Jeha S; Wolf J
Cancer Med; 2020 Sep; 9(18):6550-6555. PubMed ID: 32710497
[TBL] [Abstract][Full Text] [Related]
14. Moxifloxacin versus levofloxacin for antibacterial prophylaxis in acute leukemia patients.
Lee P; Knoebel RW; Pisano J; Pettit NN
J Oncol Pharm Pract; 2019 Apr; 25(3):758-761. PubMed ID: 29310512
[TBL] [Abstract][Full Text] [Related]
15. Antibiotic prophylaxis and the gastrointestinal resistome in paediatric patients with acute lymphoblastic leukaemia: a cohort study with metagenomic sequencing analysis.
Margolis EB; Hakim H; Dallas RH; Allison KJ; Ferrolino J; Sun Y; Pui CH; Yao J; Chang TC; Hayden RT; Jeha S; Tuomanen EI; Tang L; Rosch JW; Wolf J
Lancet Microbe; 2021 Apr; 2(4):e159-e167. PubMed ID: 34355208
[TBL] [Abstract][Full Text] [Related]
16. Antibiotic prophylaxis with teicoplanin on alternate days reduces rate of viridans sepsis and febrile neutropenia in pediatric patients with acute myeloid leukemia.
Boztug H; Mühlegger N; Pötschger U; Attarbaschi A; Peters C; Mann G; Dworzak M
Ann Hematol; 2017 Jan; 96(1):99-106. PubMed ID: 27699447
[TBL] [Abstract][Full Text] [Related]
17. Ciprofloxacin reduces occurrence of fever in children with acute leukemia who develop neutropenia during chemotherapy.
Laoprasopwattana K; Khwanna T; Suwankeeree P; Sujjanunt T; Tunyapanit W; Chelae S
Pediatr Infect Dis J; 2013 Mar; 32(3):e94-8. PubMed ID: 23080291
[TBL] [Abstract][Full Text] [Related]
18. Levofloxacin prophylaxis in hospitalized children with leukemia: A cost-utility analysis.
Maser B; Pelland-Marcotte MC; Alexander S; Sung L; Gupta S
Pediatr Blood Cancer; 2020 Oct; 67(10):e28643. PubMed ID: 32785971
[TBL] [Abstract][Full Text] [Related]
19. Obesity is not strongly associated with increased risk for febrile neutropenia during levofloxacin prophylaxis in patients with hematological malignancies receiving intermediate-risk myelosuppressive chemotherapy.
Kurtti A; Fritz K; Elofson-Disney K; Benefield R
J Oncol Pharm Pract; 2020 Sep; 26(6):1301-1305. PubMed ID: 31810423
[TBL] [Abstract][Full Text] [Related]
20. [Levofloxacin prophylaxis in neutropenic patients].
Carena AA; Jorge L; Bonvehí P; Temporiti E; Zárate MS; Herrera F
Medicina (B Aires); 2016; 76(5):295-303. PubMed ID: 27723617
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]